Connect Biopharma Holdings (Connect Biopharma Holdings) Accounts Payable & Accrued Expense : $10.66 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Accounts Payable & Accrued Expense?

Connect Biopharma Holdings's quarterly accounts payable & accrued expense declined from Dec. 2022 ($15.44 Mil) to Jun. 2023 ($14.60 Mil) and declined from Jun. 2023 ($14.60 Mil) to Dec. 2023 ($10.66 Mil).

Connect Biopharma Holdings's annual accounts payable & accrued expense declined from Dec. 2021 ($17.89 Mil) to Dec. 2022 ($15.44 Mil) and declined from Dec. 2022 ($15.44 Mil) to Dec. 2023 ($10.66 Mil).

Connect Biopharma Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Connect Biopharma Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Accounts Payable & Accrued Expense Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

3.86

5.72

17.89

15.44

10.66

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial				17.89	20.45	15.44	14.60	10.66

Connect Biopharma Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.